Used together or in combination, these apps address the things that actually determine long-term success on GLP-1 therapy: consistency, nutrition quality, strength maintenance, and mindset
Among the most promising non-incretin receptor targets are amylin (Amy) receptors (AMYRs), supported by data from phase I and phase II clinical trials showing efficacy of the long-acting amylin and calcitonin receptor agonist, cagrilinitide (Cagri), both as monotherapy 2,3 and in combination with the selective GLP-1R agonist, semaglutide 4,5
Sometimes resilience is refusing to make medical decisions while you are emotionally cornered
The specific medication, formulation, and dosing strategy are determined by a licensed medical provider based on an individuals medical history, treatment goals, and approved indications
Polyethylene glycol 3350 (MiraLAX) is generally recommended as first-line pharmacologic therapy because it is safe for extended use, does not cause electrolyte disturbances when used as directed, and effectively softens stool by drawing water into the intestinal lumen
